Crinetics asks Nasdaq to suspend trading, delist via Form 25
Ahead of its merger, Crinetics asked Nasdaq to suspend trading prior to the market open on the Closing Date. It requested Form 25 delist/deregister under Section 12(b) and plans Form 15 after Form 25 is effective.
In connection with its merger, the company has asked Nasdaq to suspend trading in its common stock before the market open on the Closing Date and has requested that Nasdaq file Form 25 to delist and deregister the shares under Section 12(b). Once Form 25 becomes effective, the company plans to file Form 15.